Unofficial translation
In accordance with paragraph 1-1 of Article 5 of the Law of the Republic of Kazakhstan “On narcotic drugs, psychotropic substances, their analogues and precursors and measures to combat their illicit circulation and abuse,” the Government of the Republic of Kazakhstan HEREBY DECREES:
Footnote. Preamble - as amended by the Decree of the Government of the Republic of Kazakhstan dated 23.01.2024 № 22 (shall come into effect ten calendar days after the day of its first official publication).1. Approve the attached:
1) The List of Narcotic Drugs, Psychotropic Substances and Precursors to be controlled in the Republic of Kazakhstan;
2) The Summary table on classification of Narcotic Drugs, Psychotropic Substances, their Analogues and Precursors found in Illicit Trafficking, to small, large and especially large sizes;
3) A List of substituents of hydrogen atoms, halogens and (or) hydroxyl groups in the structural formulas of Narcotic Drugs, Psychotropic Substances.
2. This Decree shall be enforced from July 5, 2019 and subject to official publication.
The Prime Minister of the Republic of Kazakhstan | A. Mamin |
Approved by the Decree of the Government of the Republic of Kazakhstan № 470 dated July 3, 2019 |
List of Narcotic Drugs, Psychotropic Substances and Precursors to be controlled
in the Republic of Kazakhstan TABLE I LIST OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES, THE USE OF WHICH FOR MEDICAL PURPOSES IS PROHIBITED
Footnote. List as amended by Decrees of the Government of the Republic of Kazakhstan dated September 27, 2021 № 677 (shall be enforced ten calendar days after the day of its first official publication); dated 23.05.2022 № 326 (shall be enforced upon the expiration of ten calendar days after the day of its first official publication); dated 20.03.2023 № 240 (shall be enforced upon the expiration of ten calendar days after the day of its first official publication); dated 23.01.2024 № 22 (shall come into effect upon the expiration of ten calendar days after the day of its first official publication).
A. NARCOTICS
1. | ALLILPRODINE |
2. | ALFAMEPRODINE |
3. | ALFAMETADOL |
4. | ALPHA-METHYLFENTANIL |
5. | ALPHA-METHYLTHIOFENTANIL |
6. | ALFAPRODIN |
7. | ANILERIDINE |
8. | ACETYL-ALPHA-METHYLFENTANIL |
9. |
ACETYLATED OPIUM |
10. | ACETORFIN |
11. | BENZETIDINE |
12. | BEZITRAMIDE |
13. | BETA-HYDROXY-3-METHYLFENTANIL |
14. | BETA HYDROXY FENTANYL |
15. | BETAMEPRODINE |
16. | BETAMETADOL |
17. | BETAPRODIN |
18. | BETACETYLMETHADOL |
19. |
HASHISH, ANASHA |
20. | HEROIN |
21. | HYDROXYPETHIDINE |
22. | DESOMORPHINE |
23. | DIAMPROMIDE |
24. | DIFENOXIN |
25. | DIETHYLTHIAMBUTENE |
26. | DIMENOXADOL |
27. | DIMEPHEPTANOL |
28. | DIMETHYLTHIAMBUTENE |
29. | DIOXAPHETYL BUTYRATE |
30. | DIPIPANON |
31. | DROTEBANOL |
32. | ISOMETHADONE |
33. | MARIJUANA (CANNABIS) (CANNABIS)-crushed or not crushed apical parts of a plant of the genus Cannabis leaves and inflorescences in dried or non-dried form. |
34. | KETOBEMIDONE |
35. | KLONITAZEN |
36. | KODOKSIM |
37. | COCAINE other than cocaine hydrochloride |
38. |
COCA LEAF |
39. |
Poppy straw: |
40. | METHADONE INTERMEDIATE |
41. | 3-METHYLFENTANIL |
42. | 3-METHYLTHIOPENTANIL |
43. |
0-3-Monoacetylmorphine |
44. |
0-6-Monoacetylmorphine |
45. | MORAMIDA, INTERMEDIATE PRODUCT |
46. | MORPHINEMETHOBROMIDE and other morphine methylates |
47. | MORPHINE-N-OXIDE |
48. | MPPP |
49. | NORACIMETADOL |
50. | NORCODEIN |
51. | NORMETADONE |
52. | NORMORFIN |
53. | NORPIPANON |
54. | OPIUM (HYPNOTIC) POPPY |
55. | ACETYL FENTANYL |
56. | PEPAP |
57. | PETHIDINE |
58. | PETHIDINE INTERMEDIATE A, B, C |
59. | PIMINODINE |
60. | PROHEPTAZIN |
61. | PROPERIDINE |
62. | CANNABIS PLANT (HEMP) - any plant of the genus Cannabis, with or without a root, containing tetrahydrocannabinol (excluding seeds, if they are not accompanied by the plant itself or other parts of the plant), whether or not dried. |
63. |
CANNABIS RESIN |
64. | THIOFENTANIL |
65. | FENADOXONE |
66. | FENAMPROMIDE |
67. | PHENOMORPHAN |
68. | PHENOPERIDIN |
69. |
EKGONIN |
70. |
CANNABIS EXTRACT |
71. | ETHYLMETHYLTHIAMBUTENE |
72. | ETONITAZEN |
73. | ETORFIN |
74. | Mitragynine (9-methoxy-corynantheidine) |
75. | Isotonitazene |
76. | Crotonylfentanyl |
77. | Cyclopropyl fentanyl |
78. | Acryloylfentanyl (Acrylfentanyl) |
79. | Furanylfentanyl |
80. | Tetrahydrofuranylfentanyl (THF-F) |
81. | U-47700 |
82. | MT-45 |
83. | AH-7921 |
84 | Para-fluorofentanyl (para-fluorofentanyl) |
85. | Brorfin |
86 | Metonitazene |
esters and ethers of the drugs listed in this Table, in all cases where the existence of such esters and ethers is possible;
isomers of the narcotic drugs listed in this Table, in cases where the existence of such isomers is possible (unless they are expressly excluded);
salts of all drugs listed in this Table, including salts of esters, ethers and isomers, as provided above, in all cases where the existence of such salts is possible.
Analogues of the narcotic drugs listed in section A of this table.
B. PSYCHOTROPIC SUBSTANCES
1. | AMINOREX |
2. | BROLAMPHETAMINE-DOB |
3. | DMA |
4. | DMGP |
5. | DMT |
6. | DOET |
7. | DET |
8. | CATHINONE |
9. | (+) - LYSERGIDE, LSD, LSD 25 |
10. | MDMA |
11. | 4-MTA |
12. | MECLOKVALON |
13. | METHOXETAMINE (MXE;3-MeO-2-Oxo-RCE) |
14. | MMDA |
15. | N-HYDROXY MDA |
16. | N-ETHYL MDA |
17. | MESCALINE |
18. | METAKVALONE |
19. | METHAMPHETAMINE (PERVITIN) |
20. | METHAMPHETAMINE RACEMATE |
21. | 4-METHYLAMINOREX |
22. | METHIOPROPAMINE (MPA) |
23. | METHCATHINONE (EPHEDRON) |
24. | PARAGEXIL |
25. | PARA-METHOXYMETHAMPHETAMINE (PMMA) |
26. | PYRROLIDINOVALEROPHENONE (alpha-PVP) |
27. | PMA |
28. |
KAMES (ANY PART) OF ANY TYPE OF MUSHROOMS |
29. | psilocybin |
30. | PSILOCIN, PSILOTSIN |
31. | ROLICYCLIDIN (PCP) |
32. | STP, HOUSE |
33. | TENAMPHETAMINE, MDA |
34. | TENOCIKLIDINE, TCP |
35. | TETRAHYDROCANNABINOL, all its isomers and their stereochemical variants |
36. | TMA |
37. | Phencyclidine, PCP |
38. | ETILPHENIDATE (EP; NRN) |
39. | ETHICYCLIDINE, FCG |
40. | ETRYPTAMINE |
41. | BDB |
42. | MBDB |
43. | 2-(methylamino)-1-(3,4-methylenedioxyphenyl) propan-1-one (bk -MDMA, Methylone) |
44. | 1-(3,4- methylenedioxyphenyl) -2-(pyrrolidin-1-yl) butan-1-one (MDPBP) |
45. | 2-(pyrrolidin-1- yl) -1-(thiophen-2-yl) pentan-1-one (a-PVT, a- pyrrolidinopenthiophenone) |
46. | 2-(pyrrolidin-1- yl) -1-phenylpentan-1-one (a- pyrrolidinovalerophenone, a-PVP) |
47. | 2-(pyrrolidin-1- yl) -1-phenylpropan-1-one (a- pyrrolidinopropiophenone, a- PPP) |
48. | 2-(pyrrolidin-1- yl) -1-(5,6,7,8-tetrahydronaphthalen-2-yl) pentan-1-one (TH-PVP, Tetrahydronafiron) |
49. | 2-(methylamino)-1-phenylpentan-1-one (Pentedron) |
50. | 1-(naphthalen-2- yl) -2-(pyrrolidin-1-yl) pentan-1-one (Naftylpyrovalerone, Nafiron, NRG-1) |
51. | N-methyl-1-(4-methoxyphenyl) propan-2-amine (p- Methoxymethamphetamine, PMMA) |
52. | 2-(3- methoxyphenyl) -2-(ethylamino) cyclohexan-1-one (Methoxetamine, MXE) |
53. | 2-(2,5-dimethoxy-4- chlorophenyl)- N-(2-methoxybenzyl) ethanamine (25C-NBOMe, 2C-C-NBOMe) |
54. | 3-[2-(methylamino)ethyl]-1H-indol-5-ol (5-hydroxy-N-methyltryptamine (5-HO-NMT), norbufotenine) |
55. | N-[2-(5-methoxy-1H-indol-2- yl)ethyl ]-N-(prop-2-en-1-yl) prop-2-en-1-amine (5-MeO-DALT, 5-Methoxy-N,N-diallyltryptamine) |
56. | Ethyl 2-(piperidin-2- yl) -2-phenylacetate (Ethylphenidate) |
57. | 2-(Methylamino)-1-(thiophen-2-yl) propane (Methiopropamine, MPA) |
58. | 1-Phenylpiperazine |
59. | 1-Benzylpiperazine (BZP) |
60. | 1-(1,2-diphenylethyl) piperidine (Diphenidine, DEP) |
61. |
SYNTHETIC CANNABINOIDS |
62 | 3-methoxyphencyclidine |
63 | Eutilon |
Salts of the substances listed in this Table, where the existence of such salts is possible.
Analogues of the psychotropic substances listed in section B of this table.
TABLE II LIST OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES USED FOR MEDICAL PURPOSES AND UNDER STRICT CONTROL
Footnote. List as amended by Decree of the Government of the Republic of Kazakhstan dated December 25, 2019 № 975 (shall be enforced ten calendar days after the day of its first official publication).
A. NARCOTICS
1. | ALPHACETYLMETADOL |
2. | ALFENTANIL |
3. | ACETYLDHYDROCODINE |
4. | ACETYLMETHADOL |
5. | BENZYLMORPHINE |
6. | HYDROCODONE |
7. | HYDROMORPHINOL |
8. | HYDROMORPHONE |
9. | DEXTROMORAMIDE |
10. | DEXTROPROPOXYPHENE |
11. | DIHYDROCODEINE |
12. | DIHYDROMORPHIN |
13. | DIPHENOXYLATE |
14. | CODEINE |
15. | COCAINE HYDROCHLORIDE |
16. | LEVOMETHORPHAN |
17. | LEVOMORAMIDE |
18. | LEVORPHANOL |
19. | LEVOPHENACILMORPHAN |
20. | METAZOCIN |
20-1. | METADONE |
21. | METHYLDESORPHIN |
22. | METHYLDHYDROMORPHINE |
23. | METOPON |
24. | MIROFIN |
25. | MORPHERIDINE |
26. | MORPHINE |
27. | MORPHINE HYDROCHLORIDE |
28. | NIKODYCODINE |
29. | NIKOCODIN |
30. | NYCOMORFIN |
31. | NORLEVORPHANOL |
32. | OXYCODONE |
33. | OXYMORPHONE |
34. | OMNOPON |
35. |
OPIUM |
36. | PYRITHRAMIDE (DIPIDOLOR) |
37. | PROMEDOL |
38. | PROPIRAM |
39. | PROSIDOL |
40. | RACEMETHORPHAN (DEXTROMETHORPHAN, DIMORPHAN) |
41. | RACEMORAMIDE |
42. | RACEMORPHAN |
43. | SUFENTANIL |
44. | TEBAIN (opium alkaloid) |
45. | TEBAKONE (Acetyldihydrocodeinone) |
46. | TILIDIN |
47. | TRIMEPERIDINE |
48. | PHENAZOCIN |
49. | FENTANYL |
50. |
FOLCODIN |
51. | FURETIDINE |
52. |
Extraction opium |
53. | ETHYLMORPHIN |
54. | ETOXERIDINE |
and stereoisomers of the narcotic drugs listed in this Table, where the existence of such isomers is possible within that particular chemical designation (unless they are expressly excluded);
salts of all drugs listed in this Table, including salts of isomers as provided above, where such salts may exist.
Analogues of the narcotic drugs listed in section A of this table.
B. PSYCHOTROPIC SUBSTANCES
1. | AMPHETAMINE |
2. | BUPRENORPHINE (NORFIN) |
3. | GLUTETHYMID (NOXIRON) |
4. | DEXAMPHETAMINE |
5. | LEVAMPHETAMIN |
6. | LEVOMETHAMPHETAMINE |
7. | METHYLPHENIDATE |
8. | PEMOLINE |
9. | PENTOBARBITAL |
10. | SECOBARBITAL |
11. | 2С-В |
12. | FENETILLIN |
13. | Phenmetrazine |
14. | CIPEPROL |
15. | ETHYLAMPHETAMINE |
16. | Gamma hydroxybutyric acid (GHB) |
Salts of the substances listed in this Table, where the existence of such salts is possible.
Analogues of the psychotropic substances listed in section B of this table.
TABLE III LIST OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES USED FOR MEDICAL PURPOSES AND UNDER CONTROL
Footnote. TABLE III as amended by Decree of the Government of the Republic of Kazakhstan dated March 20, 2023 № 240 (shall be enforced ten calendar days after the day of its first official publication); dated 23.01.2024 № 22 (shall come into effect upon the expiration of ten calendar days after the day of its first official publication).
A. NARCOTICS
1. Preparations of acetyldihydrocodeine, codeine, dihydrocodeine, nicocodine, nicodicodine and pholcodine, and ethylmorphine, provided that they are combined with one or more ingredients and contain no more than 100 mg of the narcotic drug per dose unit at a concentration not exceeding 2.5 percent in undivided preparations.
2. Preparations of propiram containing not more than 100 mg of propiram per dose unit and combined with at least the same amount of methylcellulose.
3. Preparations of dextropropoxyphene for oral use containing not more than 135 mg of dextropropoxyphene per dose unit and at a concentration not exceeding 2.5 per cent in undivided preparations, provided that such preparations do not contain any substance controlled under the Convention on psychotropic substances 1971.
4. Preparations of opium or morphine containing not more than 0.2 per cent morphine, calculated as anhydrous morphine base, and combined with one or more ingredients in such a way that the narcotic drug cannot be extracted from the preparation by means or in readily achievable quantities which could pose a danger to public health.
Diphenoxylate preparations containing not more than 0.5 mg of diphenoxylate per dose unit and an amount of atropine sulfate equivalent to at least 5 percent of the dose of diphenoxin.
Diphenoxylate preparations containing not more than 2.5 mg of diphenoxylate per unit dose, calculated as a base and an amount of atropine sulfate equivalent to at least 1 percent of the dose of diphenoxylate.
7. Preparations formulated according to any of the formulas indicated in this Table, and mixtures of such preparations with any substance that does not contain narcotic drugs.
Analogues of the narcotic drugs listed in section A of this table.
B. PSYCHOTROPIC SUBSTANCES
1. | ALLOBARBITAL |
2. | ALPRAZOLAM |
3. | AMOBARBITAL |
4. | AMPHEPRAMONUM |
5. | BARBITAL |
6. | BENZPHETAMINE |
7. | BROMAZEPAM |
8. | BROTIZOLAM |
9. | BUTALBITAL |
10. | BUTOBARBITAL |
11. | VINYLBITAL |
12. | GALAZEPAM |
13. | GALOXAZOLAM |
14. | DELORAZEPAM |
15. | DIAZEPAM |
16. | ZOLPIDEM |
17. | KAMAZEPAM |
18. | CATIN |
19. | KETAZOLAM |
20. | KLOBAZAM |
21. | KLOXAZOLAM |
22. | CLONAZEPAM |
23. | CLORAZEPATE |
24. | CLOTHIAZEPAM |
25. | LEPHETAMINE |
26. | LOPRAZOLAM |
27. | LORAZEPAM |
28. | LORMETAZEPAM |
29. | MAZINDOL |
30. | MEDAZEPAM |
31. | MESOCARB |
32. | MEPROBAMAT |
33. | METIPRYLON |
34. | METHYLPHENOBARBITAL |
35. | MEFENOREX |
36. | MIDAZOLAM |
37. | NIMETAZEPAM |
38. | NITRAZEPAM |
39. | NORDAZEPAM |
40. | OXAZEPAM |
41. | OXAZOLAM |
42. | PENTAZOCINE |
43. | PINAZEPAM |
44. | PIPRADROL |
45. | PYROVALERONE |
46. | PRAZEPAM |
47. | SECBUTABARBITAL |
48. | TEMAZEPAM |
49. | TETRAZEPAM |
50. | TRIAZOLAM |
51. | PHENDIMETRAZINE |
52. | FENCAMFAMIN |
53. | PHENOBARBITAL |
54. | FENPROPOREX |
55. | PHENTERMINE |
56. | FLUDIAZEPAM |
57. | FLURAZEPAM |
58. | FLUNITRAZEPAM |
59. | CHLORDIAZEPOXIDE |
60. | CYCLOBARBITAL |
61. | ESTAZOLAM |
62. | ETINAMAT |
63. | ETHYL LOFLAZEPAT |
64. | ETCHLOROVINOL |
65. | Etizolam |
66. | Tramadol |
67. | Ketamine |
68 | Clonazolam |
69 | Diclazepam |
70 | Flubromazolam |
Salts of the substances listed in this Table, in all cases where the existence of such salts is possible.
Analogues of the psychotropic substances listed in section B of this table.
TABLE IV LIST OF PRECURSORS (CHEMICAL AND PLANT SUBSTANCES FREQUENTLY USED IN THE ILLICIT MANUFACTURE OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES) UNDER CONTROL
Footnote. The list is as amended by the Decree of the Government of the Republic of Kazakhstan dated 03/20/2023 № 240 (shall be enforced ten calendar days after the day of its first official publication); as amended by the Decree of the Government of the Republic of Kazakhstan dated January 23, 2024 № 22 (shall come into effect ten calendar days after the day of its first official publication).
LIST I | LIST II |
N- acetyl anthranilic acid |
Acetic anhydride |
List
of medicines containing narcotic drugs, psychotropic substances and precursors to be
controlled in the Republic of Kazakhstan and allowed for use in veterinary medicine
А. NARCOTIC DRUGS
№ | Name |
1. | Morphine hydrochloride |
2. | Cocaine hydrochloride |
3. | Omnopon |
4. | Omnopon solution |
5. | Powder opium |
6. | Codeine preparations |
7. | Ethyl morphine preparations |
8. | Promedol |
9. | Promedol solution |
10. | Ticodine solution (codeine preparation) |
11. | Candles with opium extract (opium preparation) |
12. | Tecodine tablets (codeine preparation) |
13. | Opium tablets (codeine preparation) |
14. | Fentanyl |
15. | Dry opium extract |
16. | Opium tincture |
17. | Ethylmorphine |
18. | Hydrocodone |
В. PSYCHOTROPIC SUBSTANCES
№ | Name |
1. | Amphetamine |
2. | Pentobarbital |
3. | Barbital |
4. | Diazepam |
5. | Ketazolam |
6. | Clonazepam |
7. | Lorazepam |
8. | Meprobamat |
9. | Nitrazepam |
10. | Oxazepam |
11. | Phenobarbital |
12. | Flurazepam |
13. | Flunitrazepam |
14. | Chlordiazepoxide |
15. | Cyclobarbital |
16. | Hexanal sodium syn. Cyclobarbital |
С. PRECURSORS
№ | Name |
1. | N-acetylanthranilic acid |
2. | Lysergic acid |
3. | 3,4-methylenedioxyphenyl-propanone |
4. | 1-phenyl-2 propanone |
5. | Ergometrine |
6. | Ergotamine |
7. | Ephedrine |
8. | Ephedra Herbal |
9. | Acetic anhydride |
10. | Acetone |
11. | Methyl ethyl ketone |
12. | Potassium permanganate |
13. | Sulfuric acid |
14. | Hydrochloric acid |
15. | Piperidine |
16. | Toluene |
17. | Phenylacetic acid |
18. | Ethyl ether |
Approved by the Decree of the Government of the Republic of Kazakhstan № 470 dated July 3, 2019 |
Summary table on the classification of narcotic drugs, psychotropic substances, their analogues and precursors found in illicit circulation to small, large and especially large quantities
Footnote. The summary table - as amended by the Decree of the Government of the Republic of Kazakhstan dated 23.01.2024 № 22 (shall come into effect ten calendar days after the day of its first official publication).
Table I
Narcotic drugs | |||
Dimensions in grams | |||
Name | Small from... to… inclusive | Large over... up to... inclusive | Especially large over |
1 | 2 | 3 | 4 |
Allylprodine * | 0-0.5 | 0.5-2.5 | 2.5 |
Alfameprodine * | 0-0.5 | 0.5-2.5 | 2.5 |
Alfamethadol * | 0-0.5 | 0.5-2.5 | 2.5 |
Alpha- methylthiofentanyl * | 0.00001-0.001 | 0.001 | |
Alpha- methylfentanyl * | 0.00001- 0.001 | 0.001 | |
Alfaprodine * | 0-0.5 | 0.5-2.5 | 2.5 |
Alphacetylmethadol * | 0-0.1 | 0.1-1.5 | 1.5 |
Alfentanil * | 0-0.0002 | 0.0002 | |
Anileridine * | 0-0.01 | 0.01-0.05 | 0.05 |
Acetyl alpha- methylfentanyl * | 0.00001- 0.001 | 0.001 | |
Acetyldihydrocodeine (acetylcodeine)* | 0-0.01 | 0.01-1.0 | 1.0 |
Acetylated opium | 0-0.05 | 0.05-1.5 | 1.5 |
Acetylmethadol * | 0-0.1 | 0.1-1.5 | 1.5 |
Acetorphine * | 0 - 0.0001 | 0.0001 | |
Bezitramide * | 0-0.1 | 0.1-0.5 | 0.5 |
Benzetidine * | 0-0.05 | 0.05- 0.25 | 0.25 |
Benzylmorphine * | 0-0.2 | 0.2-10.0 | 10.0 |
Beta- hydroxy fentanyl * | 0.00001- 0.001 | 0.001 | |
Beta-hydroxy-3-methyl-fentanyl* | 0.00001- 0.001 | 0.001 | |
Betameprodine * | 0-0.5 | 0.5-2.5 | 2.5 |
Betamethadol * | 0-0.5 | 0.5-2.5 | 2.5 |
Betaprodine * | 0-0.5 | 0.5-2.5 | 2.5 |
Betacetylmethadol * | 0-0.5 | 0.5-2.5 | 2.5 |
Hashish | 0.5-5.0 | 5.0-200 | 200 |
Heroin, including related substances and excipients | 0-0.01 | 0.01-1.0 | 1.0 |
Hydrocodone * | 0-0.2 | 0.2-10.0 | 10.0 |
Hydroxypetidine * | 0-0.5 | 0.5-2.5 | 2.5 |
Hydromorphinol * | 0-0.2 | 0.2-10.0 | 10.0 |
Hydromorphone * | 0-0.2 | 0.2-10.0 | 10.0 |
Desomorphine * | 0-0.01 | 0.01-1.0 | 1.0 |
Dextromoramide * | 0-0.1 | 0.1-1.5 | 1.5 |
Dextropropoxyphene * | 0-0.1 | 0.1-1.5 | 1.5 |
Diampromide * | 0-0.01 | 0.01-1.0 | 1.0 |
Dihydrocodeine * | 0-0.2 | 0.2-10.0 | 10.0 |
Dihydromorphine * | 0-0.2 | 0.2-10.0 | 10.0 |
Dimenoxadol * | 0-0.5 | 0.5-2.5 | 2.5 |
Dimepheptanol * | 0- 0.5 | 0.5-2.5 | 2.5 |
Dimethylthiambutene * | 0-0.5 | 0.5-2.5 | 2.5 |
Dioxafetyl butyrate* | 0-0.1 | 0.1-0.5 | 0.5 |
Dipipanon * | 0-0.01 | 0.01-0.05 | 0.05 |
Diphenoxylate * | 0-0.1 | 0.1-1.5 | 1.5 |
Difenoxin * | 0-0.1 | 0.1-0.5 | 0.5 |
Diethylthiambutene * | 0-0.5 | 0.5-2.5 | 2.5 |
Drotebanol * | 0-0.01 | 0.01-1.0 | 1.0 |
Isomethadone * | 0-0.01 | 0.01-1.0 | 1.0 |
Ketobemidon * | 0-0.01 | 0.01-0.5 | 0.5 |
Clonitazene * | 0.0002-0.001 | 0.001 | |
Codeine (base and salts) and its dosage forms contain at least 0.015 g per tablet. | 0-0.2 1-14 tab. 0.015 each | 0.2-10.0 (14 tablets - 660 tablets of 0.015 each) | 10.0 (660 tablets of 0.015) |
Kodoxim * | 0-0.01 | 0.01-1.0 | 1.0 |
Cocaine (base and salts) * | 0-0.01 | 0.01-1.0 | 1.0 |
Levomethorphan * | 0-0.01 | 0.01-1.0 | 1.0 |
Levomoramide * | 0-0.01 | 0.01-1.0 | 1.0 |
Levorphanol * | 0-0.01 | 0.01-1.0 | 1.0 |
Levophenacylmorphan * | 0-0.1 | 0.1-1.5 | 1.5 |
Coca leaf | 0.5-20.0 | 20.0-500.0 | 500.0 |
|
|
| |
|
|
| |
Methadone intermediate (4-(dimethylamino)-2,2-diphenylpentanenitrile; 4-cyano-2-dimethylamino-4,4-diphenylbutane) * | 0-0.01 | 0.01-1.0 | 1.0 |
Metazocin * | 0-0.01 | 0.01-1.0 | 1.0 |
Methadone (base and salts) * | 0-0.01 | 0.01-1.0 | 1.0 |
Methyldesorphin * | 0-0.2 | 0.2-10.0 | 10.0 |
Methyldihydromorphine * | 0-0.2 | 0.2-10.0 | 10.0 |
3-Methylthiofentanyl* | 0-0.0002 | 0.0002-0.001 | 0.001 |
3-Methylfentanyl* | 0.00001- 0.001 | 0.001 | |
Metopon * | 0-0.2 | 0.2-10.0 | 10.0 |
Mirofin * | 0-0.2 | 0.2-10.0 | 10.0 |
0-3-Monoacetylmorphine* | 0-0.1 | 0.1 | |
0-6-Monoacetylmorphine* | 0-0.1 | 0.1 | |
Moramide intermediate (3-methyl-4-(morpholin-4-yl)-2,2-diphenylbutanoic acid; 2-methyl-3-morpholino-1,1-diphenylpropanecarboxylic acid)* | 0-0.5 | 0.5-2.5 | 2.5 |
Morpheridine * | 0-0.1 | 0.1-1.5 | 1.5 |
Morphine (base and salts) | 0-0.01 1 amp. 1% solution | 0.01-1.0 (from 1 to 100 amp. 1% solution) | 1.0 (100 amp. 1% solution) |
Morphine-N-oxide* | 0-0.01 | 0.01-1.0 | 1.0 |
Morphine metabromide and other morphine methylates * | 0-0.01 | 0.01-1.0 | 1.0 |
MFPP* | 0-0.5 | 0.5-2.5 | 2.5 |
Nikodikodin * | 0-0.2 | 0.2-10.0 | 10.0 |
Nicocodin * | 0-0.2 | 0.2-10.0 | 10.0 |
Nicomorphine * | 0-0.2 | 0.2-10.0 | 10.0 |
Noracimethadol * | 0-0.5 | 0.5-2.5 | 2.5 |
Norcodeine * | 0-0.01 | 0.01-1.0 | 1.0 |
Norlevorphanol * | 0-0.01 | 0.01-1.0 | 1.0 |
Normethadone * | 0-0.01 | 0.01-1.0 | 1.0 |
Normorphine * | 0-0.01 | 0.01-1.0 | 1.0 |
Norpipanone * | 0-0.01 | 0.01-0.05 | 0.05 |
Oxycodone * | 0-0.2 | 0.2-10.0 | 10.0 |
Oxymorphone * | 0-0.2 | 0.2-10.0 | 10.0 |
Omnopon (pantopon) |
0-0.03 (1-3 amp. | 0.03-3.0 (3-300 amp. 1% solution) | 3.0 (300 amp. 1% solution) |
Opium, including neutral fillers (flour, sugar, starch, etc.) | 0.1-2.0 | 2.0-100.0 | 100.0 |
Para- fluorofentanyl (para- fluorofentanyl)* | 0.00001- 0.001 | 0.001 | |
Pepup * | 0-0.5 | 0.5-2.5 | 2.5 |
Pethidine * | 0-0.5 | 0.5-2.5 | 2.5 |
Pethidine intermediate A (1-methyl-4-phenylpiperidine-4-carbonitrile; 4-cyano-1-methyl-4-phenylpiperidine), B (ethyl 4-phenylpiperidine-4-carboxylate; 4-phenylpiperidine-4-ethyl ester carboxylic acid), C (1-methyl-4-phenylpiperidine-4-carboxylic acid)* | 0-0.5 | 0.5-2.5 | 2.5 |
Piminodine * | 0-0.5 | 0.5-2.5 | 2.5 |
Piritramide (dipidolor) | 0-0.1 (1-6 amps, 2 ml each) | 0.1-1.5 (6-100 amps, 2 ml each) | 1.5 (100 amp. 2 ml each) |
Proheptazine * | 0-0.5 | 0.5-2.5 | 2.5 |
Promedol (trimeperidine) | 0-0.03 (1-3 amp. 1% solution) | 0.03-3.0 (3-300 amp. 1% solution) | 3.0 (300 amp. 1% solution) |
Properidine * | 0-0.5 | 0.5-2.5 | 2.5 |
Propyram * | 0-0.1 | 0.1-1.5 | 1.5 |
Prosidol * | 0-0.1 | 0.1-1.5 | 1.5 |
Soporific poppy plant (opium poppy) | 5-200 | 200-10000 | 10000 |
Racemethorphan (dextramethorphan, dimorphan)* | 0-0.1 | 0.1-1.5 | 1.5 |
Racemoramide * | 0-0.1 | 0.1-1.5 | 1.5 |
Racemorphan * | 0-0.01 | 0.01-1.0 | 1.0 |
Cannabis resin | 0.1-0.5 | 0.5-40.0 | 40.0 |
Sufentanil * |
0-0.0002 1-20 amp. |
0.0002 20 amp. | |
Thebaine * | 0-0.2 | 0.2-10.0 | 10.0 |
Tebacon * | 0-0.2 | 0.2-10.0 | 10.0 |
Tilidin * | 0-0.01 | 0.01-1.0 | 1.0 |
Thiofentanyl * | 0-0.0002 | 0.0002-0.001 | 0.001 |
Phenadoxone * | 0-0.5 | 0.5-2.5 | 2.5 |
Phenazocine * | 0-0.01 | 0.01-1.0 | 1.0 |
Fenampromide * | 0-0.5 | 0.5-2.5 | 2.5 |
Phenomorphan * | 0-0.01 | 0.01-1.0 | 1.0 |
Phenoperidine * | 0-0.5 | 0.5-2.5 | 2.5 |
Fentanyl * |
0-0.0002 1-20 amp. |
0.0002 20 amp. | |
Folkodin * | 0-0.2 | 0.2-10.0 | 10.0 |
Furetidine * | 0-0.1 | 0.1-1.5 | 1.5 |
Ecgonine and its esters and derivatives, which can be converted to ecgonine and cocaine | 0-0.01 | 0.01-1.0 | 1.0 |
Cannabis extract (hashish oil) | 0-0.05 | 0.05-50.0 | 50.0 |
Extraction opium | 0-0.1 | 0.1-3.0 | 3.0 |
Ethylmethylthiambutene | 0-0.5 | 0.5-2.5 | 2.5 |
Ethylmorphine, ethylmorphine hydrochloride (dionine) | 0-0.02 (1-2 tablets of 0.01 each) | 0.02-2.0 (2-1000 tablets of 0.01 each) | 2.0 (1000 tablets of 0.01 each) |
Ethoxyridine | 0-0.1 | 0.1-1.5 | 1.5 |
Etonitazene | 0.0001-0.001 | 0.001 | |
Etorphine | 0-0.0001 | 0.001 | |
Mitragynine (9-methoxy-corynantheidine) * | 0-0.01 | 0.01-1.0 | 1.0 |
Acetyl fentanyl * |
0-0.0002 1-20 amp. |
0.0002 20 amp. | |
Isotonitazene | 0.0001-0.001 | 0.001 | |
Crotonylfentanyl | 0.0002-0.001 | 0.001 | |
Cyclopropyl fentanyl | 0.0002-0.001 | 0.001 | |
Acryloyl fentanyl (acrylfentanyl) | 0.0002-0.001 | 0.001 | |
Furanylfentanyl | 0.0002-0.001 | 0.001 | |
Tetrahydrofuranyl fentanyl (THF-F) | 0.0002-0.001 | 0.001 | |
U-47700 | 0-0.01 | 0.01-1.0 | 1.0 |
MT-45 | 0-0.01 | 0.01-1.0 | 1.0 |
AH-7921 | 0-0.01 | 0.01-1.0 | 1.0 |
Brorfin | 0-0.1 | 0.1-0.5 | 0.5 |
Metonitazene | 0.0001-0.001 | 0.001 |
The quantities of analogues of narcotic drugs correspond to the quantities of the drugs of which they are analogues.
*Dimensions apply to mixtures (preparations) of the specified narcotic drug and its analogues.
Table II
Psychotropic substances | |||
Dimensions in grams | |||
Name | Small from... to… inclusive | Large over... up to... inclusive | Especially large over |
1 | 2 | 3 | 4 |
Allobarbital * | 0-0.6 | 0.6-30.0 | 30.0 |
Alprazolam * | 0.5-5.0 | 5.0 | |
Aminorex * | 0-0.01 | 0.01-0.1 | 0.1 |
Amobarbital (barbamyl) | 0-0.6 (1-6 tablets of 0.1 each) | 0.6-30.0 (6-300 tablets of 0.1 each) | 30.0 (300 tablets of 0.1 each) |
Amphetamine (base and salts)* | 0-0.2 | 0.2-3.0 | 3.0 |
Amfepramone (Fepranon) | 0-0.125 (1-5 tablets of 0.025 each) | 0.125-7.5 (5-300 tablets of 0.025 each) | 7.5 (300 tablets of 0.025 each) |
Barbital * | 0-0.6 | 0.6-30.0 | 30.0 |
BDB (base and salts)* | 0-0.02 | 0.02-1.0 | 1.0 |
Benzphetamine * | 0-0.2 | 0.2-3.0 | 3.0 |
Brolamphetamine (DOB) (base and salts)* | 0-0.001 | 0.001 | |
Bromazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Brotizolam * | 0-0.5 | 0.5-5.0 | 5.0 |
Buprenorphine (norphine, sangesik, tengesik buprenal, buprenone) | 0-0.0012 (1-4 amps of 1 ml, 1-2 amps of 2 ml, 1-6 amps of 2 ml, tablets of 0.2 mg) | 0.0012-0.12 (4-400 amp. 1 ml, 2-200 amp. 2 ml, 6-600 tablets 0.2 mg) | 0.12 (400 amps of 1 ml, 200 amps of 2 ml, 600 tablets of 0.2 mg) |
Butalbital * | 0-0.6 | 0.6-30.0 | 30.0 |
Butobarbital * | 0-0.6 | 0.6-30.0 | 30.0 |
Vinylbital * | 0-0.6 | 0.6-30.0 | 30.0 |
Galazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Haloxazolam * | 0-0.5 | 0.5-5.0 | 5.0 |
Glutethimide (Noxiron) (base and salts) | 0-1.5 (1-6 tablets of 0.25 each) | 1.5-25.0 (6-100 tablets of 0.25 each) | 25.0 (100 tablets of 0.25 each) |
GHB - gamma-hydroxybutyric acid* | 0-0.6 | 0.6-30.0 | 30.0 |
Dexamphetamine * | 0-0.2 | 0.2-3.0 | 3.0 |
Delorazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Diazepam and other benzodiazepine derivatives indicated in Table III | 0.5-5.0 (100-1000 tablets of 5 mg) | 5.0 (1000 tablets of 5 mg) | |
Dimethyltryptamine (DMT) (base and salts)* | 0-0.02 | 0.02-1.0 | 1.0 |
Diethyltryptamine (DET) (base and salts)* | 0-0.02 | 0.02-1.0 | 1.0 |
DMA (base and salts)* | 0-0.02 | 0.02-1.0 | 1.0 |
DMGP* | 0-0.05 | 0.05-5.0 | 5.0 |
DOET (base and salts)* | 0-0.001 | 0.001 | |
Zolpidem * | 0-0.6 | 0.6-30 | 30.0 |
Camazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Catine (norpseudoephedrine)* | 0-0.2 | 0.2-3.0 | 3.0 |
Cathinone * | 0-0.02 | 0.02-1.0 | 1.0 |
Ketazolam * | 0-0.5 | 0.5-5.0 | 5.0 |
Clobazam * | 0-0.5 | 0.5-5.0 | 5.0 |
Cloxazolam * | 0-0.5 | 0.5-5.0 | 5.0 |
Clonazepam | 0.5-5.0 (255-2550 tablets of 2 mg) (500 tablets of 1 mg) | 5.0 (2550 tablets of 2 mg) (500 tablets of 1 mg) | |
Clorazepate * | 0-0.5 | 0.5-5.0 | 5.0 |
Clotiazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Levamphetamine * | 0-0.2 | 0.2-3.0 | 3.0 |
Levomethamphetamine * | 0-0.2 | 0.2-3.0 | 3.0 |
Lefetamine * | 0-0.2 | 0.2-3.0 | 3.0 |
(+)- Lysergide (LSD, LSD-25)* | 0-0.0001 | 0.0001 | |
Loprazolam * | 0-0.5 | 0.5-5.0 | 5.0 |
Lorazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Lormetazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Mazindol * | 0-0.2 | 0.2-3.0 | 3.0 |
MBDB (base and salts)* | 0-0.02 | 0.02-1.0 | 1.0 |
MDMA (base and salts)* | 0-0.02 | 0.02-1.0 | 1.0 |
Medazepam | 0-0.5 | 0.5-5.0 (50-500 tablets of 10 mg) | 5.0 (500 tablets of 10 mg) |
Mesocarb * | 0-0.2 | 0.2-3.0 | 3.0 |
Mecloqualone * | 0-0.05 | 0.05-1.0 | 1.0 |
Meprobamate * | 0-0.5 | 0.5-5.0 | 5.0 |
Mescaline (base and salts)* | 0-0.3 | 0.3-5.0 | 5.0 |
Methaqualone (base and salts)* | 0-0.05 | 0.05-1.0 | 1.0 |
Methamphetamine, pervitin (base and salts, including related substances)* | 0-0.02 | 0.02-1.5 | 1.5 |
Methamphetamine racemate* | 0-0.02 | 0.02-1.5 | 1.5 |
4-Methylaminorex* | 0-0.01 | 0.01-0.1 | 0.1 |
4-MTA (4-methylthioamphetamine)* | 0-0.02 | 0.02-1.0 | 1.0 |
2-(methylamino)-1-(3,4-methylenedioxyphenyl) propan-1-one (bk -MDMA, Methylone)* | 0-0.02 | 0.02-1.5 | 1.5 |
Methylphenidate * | 0-0.1 | 0.1-1.5 | 1.5 |
Methylphenobarbital * | 0-0.6 | 0.6-30.0 | 30.0 |
Methiprilone * | 0-0.1 | 0.1-1.5 | 1.5 |
Methcathinone (ephedrone)* | 0-0.02 | 0.02-1.5 | 1.5 |
Mefenorex * | 0-0.2 | 0.2-30.0 | 30.0 |
Midazolam * | 0-0.5 | 0.5-5.0 | 5.0 |
MMDA (base and salts)* | 0-0.02 | 0.02-1.0 | 1.0 |
Nimetazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Nitrazepam | 0.5-5.0 (100-1000 tablets of 5 mg) | 5.0 (1000 tablets of 5 mg) | |
Nordazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Oxazepam, nozepam | 0.5-5.0 (50-500 tablets of 10 mg) | 5.0 (500 tablets of 10 mg) | |
Oxazolam * | 0-0.5 | 0.5-5.0 | 5.0 |
Parahexyl (synhexyl)* | 0-0.05 | 0.05-5.0 | 5.0 |
Pemoline * | 0-0.2 | 0.2-3.0 | 3.0 |
Pentazocine (fortral) | 1 tablet of 0.05 g, 1 amp. 0.03 g each | 1-100 tab. 0.05 g each, 1-100 amp. 0.03 g each | 100 tab. 0.05 g each, 100 amp. 0.03 g each |
Pentobarbital * | 0-0.5 | 0.5-5.0 | 5.0 |
Pinazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Pipradrol * | 0-0.1 | 0.1-1.5 | 1.5 |
Pyrovalerone * | 0-0.01 | 0.01-1.0 | 1.0 |
Fruiting body of mushrooms containing psilocin and psilocybin | 0-0.5 | 0.5-50.0 | 50.0 |
PMA (base and salts)* | 0-0.02 | 0.02-1.0 | 1.0 |
Prazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Drugs containing amphetamine (Afin, phenamine) | 0-1 ml | 1.0-50.0 ml | 50.0 ml |
Psilocybin * | 0-0.01 | 0.01-0.1 | 0.1 |
Psilocin (psilotsin)* | 0-0.01 | 0.01-0.1 | 0.1 |
Rolicyclidine (FCP) (base and salts)* | 0-0.01 | 0.01 | |
2С-В* | 0- 0.01 | 0.01-0.05 | 0.05 |
Secbutabarbital * | 0-0.6 | 0.6-30.0 | 30.0 |
Secobarbital * | 0-0.6 | 0.6-30.0 | 30.0 |
STP, DOM (base and salts)* | 0-0.002 | 0.002 | |
Temazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Tenamphetamine (MDA), (base and salts)* | 0-0.02 | 0.02-1.0 | 1.0 |
Tenocyclidine (TCP, TCP) (base and salts)* | 0-0.01 | 0.01 | |
Tetrahydrocannabinol (its isomers) | 0-0.05 | 0.05-5.0 | 5.0 |
Tetrazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
TMA* | 0-0.02 | 0.02-1.0 | 1.0 |
Triazolam (halcion)* | 0.5-5.0 | 5.0 | |
Phendimetrazine * | 0-0.2 | 0.2-3.0 | 3.0 |
Phenethylline * | 0-0.2 | 0.2-3.0 | 3.0 |
Phencamfamin * | 0-0.2 | 0.2-3.0 | 3.0 |
Phenmetrazine * | 0-0.1 | 0.1-1.0 | 1.0 |
Phenobarbital * | 0-0.6 | 0.6-30.0 | 30.0 |
Fenproporex * | 0-0.2 | 0.2-3.0 | 3.0 |
Phentermine * | 0-0.1 | 0.1-1.0 | 1.0 |
Phencyclidine (base and salts)* | 0-0.01 | 0.01 | |
Fludiazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Flunitrazepam * | 0.5-5.0 | 5.0 | |
Flurazepam * | 0-0.5 | 0.5-5.0 | 5.0 |
Chlordiazepoxide * | 0.5-5.0 | 5.0 | |
Cyclobarbital * | 0-0.6 | 0.6-30.0 | 30.0 |
Zipeprol * | 0-0.5 | 0.5-3.0 | 3.0 |
Etryptamine * | 0-0.5 | 0.5-2.5 | 2.5 |
Estazolam * | 0-0.5 | 0.5-5.0 | 5.0 |
Ethyl loflazepate * | 0-0.5 | 0.5-5.0 | 5.0 |
Ethylamphetamine * | 0-0.2 | 0.2-3.0 | 3.0 |
Ethyl 2-(piperidin-2-yl) -2-phenylacetate (ethylphenidate; EP; EPH)* | 0-0.2 | 0.2-3.0 | 3.0 |
Etinamate * | 0-0.5 | 0.5-5.0 | 5.0 |
Ethycyclidine (FCG) (base and salts)* | 0-0.01 | 0.01 | |
Ethchlorovinol * | 0-0.6 | 0.6-30.0 | 30.0 |
N-ethyl-MDA (MDEA) (base and salts) * | 0-0.02 | 0.02-1.0 | 1.0 |
N- hydroxy -MDA (base and salts) * | 0-0.02 | 0.02-1.0 | 1.0 |
N- benzylpiperazine (1-benzylpiperazine; BZP) * | 0-0.3 | 0.3-1.5 | 1.5 |
1-Phenylpiperazine* | 0-0.3 | 0.3-1.5 | 1.5 |
1-(3,4-methylenedioxyphenyl) -2- (pyrrolidin-1-yl) butan-1-one (MDPBP)* | 0-0.01 | 0.01-1.0 | 1.0 |
1-(1,2-diphenylethyl) piperidine (Diphenidine, DEP) * | 0-0.01 | 0.01-1.0 | 1.0 |
1-(naphthalen-2-yl) -2-(pyrrolidin-1-yl) pentan-1-one (naphthylpyrovalerone; nafiron; NRG-1) * | 0-0.01 | 0.01-1.0 | 1.0 |
2-(pyrrolidin-1-yl) -1-phenylpentan-1-one pyrrolidinovalerophenone; pyrrolidinopentiophenone; alpha-PVP) * | 0-0.01 | 0.01-1.0 | 1.0 |
2-(pyrrolidin-1-yl) -1-(thiophen-2-yl) pentan-1-one (a-PVT; a- pyrrolidinopenthiophenone) * | 0-0.01 | 0.01-1.0 | 1.0 |
2-(pyrrolidin-1-yl) -1-phenylpropan-1-one (a- pyrrolidinopropiophenone, a-PPP) * | 0-0.01 | 0.01-1.0 | 1.0 |
2-(pyrrolidin-1-yl) -1-(5,6,7,8-tetrahydronaphthalene-2-yl) pentan-1-one (TH-PVP, tetrahydronaphyrone)* | 0-0.01 | 0.01-1.0 | 1.0 |
2-(methylamino)-1-phenylpentan-1-one (pentedrone; a- methylaminovalerophenone) * | 0-0.01 | 0.01-1.0 | 1.0 |
2-(3-methoxyphenyl) -2- (ethylamino) cyclohexan-1-one (methoxetamine, MCE; 3-MeO-2-0ho-PCE) * | 0-0.01 | 0.01-1.0 | 1.0 |
2-(2,5-dimethoxy-4-chlorophenyl) -N-(2-methoxybenzyl) ethanamine (25C-NBOMe, 2C-C-NBOMe) * | 0-0.02 | 0.02-0.5 | 0.5 |
2-(methylamino)-1-(thiophen-2-yl) propane (methiopropamine, MPA)* | 0-0.02 | 0.02-1.5 | 1.5 |
3-[2-(methylamino) ethyl]-1H-indol-5-ol (5-hydroxy-N-methyltryptamine; 5-HO-NMT; norbufotenine)* | 0-0.05 | 0.05-1.0 | 1.0 |
N-methyl-1-(4-methoxyphenyl) propan-2-amine (para- methoxymethamphetamine, PMMA)* | 0-0.2 | 0.2-3.0 | 3.0 |
N-[2-(5-methoxy-1H-indol-2-yl) ethyl]-N-(prop-2-en-1-yl) prop-2-en-1-amine (5-MeO-DALT; 5-methoxy-N,N-diallyltryptamine)* | 0-0.05 | 0.05-1.0 | 1.0 |
Synthetic cannabinoids * | 0-0.01 | 0.01-1.0 | 1.0 |
Etizolam * | 0.5-5.0 | 5.0 | |
Tramadol (2-[(dimethylamino)methyl]-1-(3-methoxyphenyl) cyclohexanol; (+/-)-trans-2-[(dimethylamino) methyl]-1-(m-methoxyphenyl)cyclohexanol hydrochloride)* | 0-0.1 | 0.1-10 | 10 |
Ketamine * | 0-0.01 | 0.01 | |
3-methoxyphencyclidine | 0-0.01 | 0.01 | |
Eutilon | 0-0.02 | 0.02-1.5 | 1.5 |
Clonazolam | 0.5-5.0 | 5.0 | |
Diclazepam | 0.5-5.0 | 5.0 | |
Flubromazolam | 0.5-5.0 | 5.0 |
The quantities of analogues of psychotropic substances correspond to the quantities of psychotropic substances of which they are analogues.
*Dimensions shall apply to mixtures (preparations) of the specified psychotropic substance and its analogues.
Table III
Precursors | |||||
Dimensions in grams | |||||
Name | Chemical name or analogue | Concentration | Small from... to… inclusive | Large over... up to... inclusive | Especially large over |
1 | 2 | 3 | 4 | 5 | 6 |
N- acetylanthranium lic acid | 2 acetyl amine benzoic acid | 15% or more | 0-60.0 | 60.0-11500 | 11500 |
Isosafrole | 1,3 benzodioc sol,5-(1-propenyl) - | 15% or more | 0-20.0 | 20.0-3500 | 3500 |
Lysergic acid | ((8ß)9,10-didehydro-6-methylylgoline-8-carboxylic acid) | 10% or more | 0-0.005 | 0.005-1.0 | 1.0 |
3,4-methylenedioxyphenyl-2-propanone | 1- (benzo [d][1,3]dioxol-5-yl) propan-2-one | 15% or more | 0-10.0 | 10.0-2000 | 2000 |
Norephedrine (phenylpropanolamine) | (R*, S*)- ą-(1-aminoethyl) benzenemethanol | 10% or more | 1.0-10.0 | 10.0-50.0 | 50.0 |
Piperonal | 1,3-benzodioc sol-5-carboxaldehyde | 15% or more | 0-20.0 | 20.0-3500 | 3500 |
Pseudoephedrine | [S-(R*,R*)]-ą-[1-(methylamino) ethyl] -benzene methanol | 10% or more | 1.0-10.0 | 10.0-50.0 | 50.0 |
Safrole, including sassafras oil | 5-(2-propenyl) -1,3-benzodioxole | regardless of concentration | 0-20.0 | 20.0-3500 | 3500 |
1-phenyl-2-propanone | phenylacetone, P-2-P | regardless of concentration | 0-20.0 | 20.0-3500 | 3500 |
Ergometrine | ergoline-8-carboxamide, 9,10-didehydro-N-(2-hydroxy-1-methylethyl) -6-methyl-[8ß(S)] | 10% or more | 0.2-10.0 | 10.0-50.0 | 50.0 |
Ergotamine | ergotaman-3-6,18-trione,12-hydroxy-2-methyl-5-(phenylmethyl)-, (5ą) | 10% or more | 4.0-10.0 | 10.0-50.0 | 50.0 |
Ephedrine | [R-(R*, S*,)]-ą-[1-(methylamino) ethyl] -benzenemethanol | 10% or more | 1.0-10.0 | 10.0-50.0 | 50.0 |
Acetic anhydride | ethane anhydride | 10% or more | 0-100.0 | 100.0-100000 | 100000 |
Anthranilic acid | 2-aminobenzoic acid | 15% or more | 0-60.0 | 60.0-11500 | 11500 |
Acetone | 2-propanone | 60% or more | 0-100.0 | 100.0-100000 | 100000 |
Acetyl chloride | acetyl chloride; acetic acid chloride | 40% or more | 0-100.0 | 100.0-100000 | 100000 |
Acetonitrile | 15% or more | 0-100.0 | 100.0-100000 | 100000 | |
Benzyl chloride | (chloromethyl)benzene | 40% or more | 0-100.0 | 100.0-100000 | 100000 |
Benzyl cyanide | 2-phenylace tonitrile | 40% or more | 0-100.0 | 100.0-100000 | 100000 |
Methylamine | methanamine; aminomethane | 40% or more | 0-100.0 | 100.0-100000 | 100000 |
Methyl ethyl ketone | 2-butanone | 80% or more | 0-50.0 | 50.0-5000 | 5000 |
Norfentanil | N-(piperidin-4-yl)-N- phenylpropanamide | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 |
Nitromethane | 40% or more | 0-100.0 | 100.0-100000 | 100000 | |
Potassium permanganate | KMnO4 | 80% or more | 0-100.0 | 100.0-100000 | 100000 |
Sulfuric acid | H2SO4 | 45% or more | 0-100.0 | 100.0-100000 | 100000 |
Hydrochloric acid | HCl | 15% or more | 0-100.0 | 100.0-100000 | 100000 |
Tetrahydrofuran | THF; oxolan; tetramethylene oxide | 45% or more | 0-100.0 | 100.0-100000 | 100000 |
Thionyl chloride | thionyl chloride; sulfuric acid chloride | 40% or more | 0-100.0 | 100.0-100000 | 100000 |
Piperidine | azocyclohexane; hexahydropyridine | 15% or more | 0-10.0 | 10.0-100.0 | 100.0 |
Toluene | methylbenzene | 70% or more | 0-100.0 | 100.0-10000 | 10000 |
Acetic acid | ethanoic acid | 80% or more | 0-100.0 | 100.0-100000 | 100000 |
Phenylacetic acid | alpha- toluic acid; 2-phenylacetic acid | 15% or more | 0-100.0 | 100.0-10000 | 10000 |
Ethyl ether | diethyl ether; ethoxyethane | 45% or more | 0-100.0 | 100.0-10000 | 10000 |
Ephedra, dried, undried |
|
|
| ||
Methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (PLA glycidate) | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
3-1,3-benzodioc | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
Alpha- acetylphenylacetonitrile | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
1-(2-phenylethyl)-4-anilinopiperi | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
N-phenethyl-4-piperidinone (1-(2-phenylethyl) piperidin-4-one) (NPP) | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
2-bromo-1-(4-methylphenyl) propan-1-one | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
2-bromo-1-phenylpentan-1-one | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
1-phenylpentan-1-one | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
1-(1,3-benzodioxol-5-yl) pentan-1-one | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
2-bromo-1-phenylhexan-1-one | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
2-bromo-1-phenylpropan-1-one | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
2-iodo-1-(4-methylphenyl) propan-1–one | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
1-(4-methylphenyl)pentan-1-one | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
1-(4-methoxyphenyl) pentan-1-one | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
1-(3,4-dimethylphenyl) pentan-1-one | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
1-(4-fluorophenyl) pentan-1-one | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 | |
1-boc-4-AP | tert-butyl 4-(phenylamino) piperidine-1-carboxylate | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 |
4-AR | N-phenyl-4-piperidinamine | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 |
4-methylpropiophenone | (1-(4-methylphenyl) -1-propanone) | regardless of concentration | 0-100.0 | 100.0-100000 | 100000 |
The extent of illegal cultivation of plants classified as narcotic drugs, psychotropic substances and precursors
Table IV
When determining the quantity of narcotic drugs, psychotropic substances, their analogues and precursors in illegal possession, in the form of solutions, extracts, as well as tampons, gauze, bandages, plant particles, paper and others soaked in these substances, it shall be necessary to carry out extraction of this type of specific drug or substance with subsequent recalculation of the dry residue to match the quantity of this substance or product given in the Summary Table.
Approved by the Decree of the Government of the Republic of Kazakhstan № 470 dated July 3, 2019 |
List of substituents of hydrogen atoms, halogens and (or) hydroxyl groups in the structural formulas of narcotic drugs, psychotropic substances
Footnote. List as amended by Decrees of the Government of the Republic of Kazakhstan dated December 25, 2019 № 975 (shall be enforced ten calendar days after the day of its first official publication); dated September 27, 2021 № 677 (shall be enforced upon expiration of ten calendar days after the day of its first official publication); dated 20.03.2023 № 240 (shall be enforced upon the expiration of ten calendar days after the day of its first official publication); as amended by the Decree of the Government of the Republic of Kazakhstan dated 23.01.2024 № 22 (shall come into effect ten calendar days after the day of its first official publication).
№ | Name | Designation |
1 | MONOVALENT SUBSTITUTES | |
1.1 | adamantanyl (adamantyl) | |
1.2 | adamantanylamino (adamantylamino) | |
1.2-1 | adamantanyloxy (adamantyloxy) | |
1.2-2 | acetyl (ethanoyl) | |
1.2-3 | acetoxy (acetyloxy) | |
1.2-4 | amino | -NH2 |
1.3 | benzyl | |
1.4 | benzylamino | |
1.5 | benzyloxy | |
1.6 | bromine | |
1.7 | butyl and its structural isomers | |
1.8 | hexyl and its structural isomers | |
1.9 | heptyl and its structural isomers | |
1.10 | hydroxy benzyl | |
1.11 | isopropyl | |
1.12 | isopropylsulfanyl (isopropylthio) | |
1.13 | iod | |
1.14 | iodobenzyl | |
1.15 | iodophenyl | |
1.16 | 1-carbamoyl-2,2-dimethylpropylamino | |
1.17 | 1-carbamoyl-2,2-dimethylpropyloxy | |
1.18 | 1-carbamoyl-2-methylpropylamino | |
1.19 | 1-carbamoyl-2-methylpropyloxy | |
1.20 | 1-carbamoyl-2-phenylethylamino | |
1.21 | methyl | |
1.22 | methylbenzyl | |
1.23 | 4-methylpiperazin-1-yl | |
1.24 | 1-methylpiperidin-2-ylmethyl | |
1.25 | 2-methylprop-2-en-1-yloxy (2-methylallyloxy) | |
1.26 | methylsulfanyl (methylthio) | |
1.27 | methylphenyl | |
1.28 | methoxy | |
1.29 | methoxybenzyl | |
1.30 | 1-methoxycarbonyl-2,2-dimethylpropylamino | |
1.31 | 1-methoxycarbonyl-2,2-dimethylpropyloxy | |
1.32 | 1-methoxycarbonyl-2-methylpropylamino | |
1.33 | 1-methoxycarbonyl-2-methylpropyloxy | |
1.34 | 1-methoxycarbonyl-2-phenylethylamino | |
1.35 | methoxyphenyl | |
1.36 | methoxyphenylamino | |
1.37 | morpholin -4-yl (morpholino) | |
1.38 | morpholin -4-ylethyl (morpholinoethyl) | |
1.39 | naphthalinyl (naphthyl) | |
1.40 | naphthalinilamino (naphthylamino) | |
1.41 | naphthalenyloxy (naphthyloxy) | |
1.42 | nitro | |
1.43 | pentyl and its structural isomers | |
1.43-1 | 2-(piperidin-1-yl) ethyl [2-piperidinylethyl] | |
1.44 | pyridinyl (pyridyl) | |
1.45 | pyrrolidinyl (pyrrolidyl) | |
1.46 | prop -2-en-1-yl (allyl) | |
1.47 | prop -2-en-1-yloxy (allyloxy) | |
1.48 | propyl | |
1.49 | propylsulfanyl (propylthio) | |
1.49-1 | (tetrahydro -2H-pyran-4-yl)methyl | |
1.50 | 2,2,3,3-tetramethyl cyclopropyl | |
1.51 | thiophenyl (thienyl) | |
1.52 | 4,4,4-trifluorobutyl | |
1.53 | trifluoromethyl | |
1.54 | phenyl | |
1.55 | phenylamino | |
1.55-1 | (2-phenylpropan-2-yl) amino | |
1.56 | phenylethyl | |
1.57 | fluorine | |
1.58 | fluorobenzyl | |
1.59 | fluoropentyl | |
1.60 | fluorophenyl | |
1.61 | quinolinyl (quinolyl) | |
1.62 | quinolilamino (quinolilamino) | |
1.63 | quinolinyloxy (quinolyloxy) | |
1.64 | chlorine | |
1.65 | chlorobenzyl | |
1.66 | chlorophenyl | |
1.67 | cyano | |
1.68 | cyclohexylmethyl | |
1.69 | ethenyl (vinyl) | |
1.70 | ethyl | |
1.71 | ethylsulfanyl (ethylthio) | |
1.72 | ethoxy | |
1.73 | Carboxamide | |
1.74 | Methoxycarbonyl | |
1.75 | Methoxymethyl | |
2 | BIVALENT SUBSTITUTES | |
2.1 | buta -1,3-diene-1,4-diyl | |
2.2 | butane -1,4-diyl (butano) | |
2.3 | methylene (methano) | |
2.4 | methylenebis (oxy) [methylenedioxy ] | |
2.5 | methyleneoxy | |
2.6 | oxy (epoxy) | |
2.7 | Oxybis (ethylene) | |
2.8 | oxo | |
2.9 | pentane -1,5-diyl (pentano) | |
2.10 | propane -1,3-diyl (propano) | |
2.11 | ethane -1,2-diyl (ethano) | |
2.12 | ethane -l,2-diylbis(oxy)[ ethylenedioxy ] | |
2.13 | ethane -1,2-diyloxy | |
2.14 | ethene -1,2-diyl (etheno) | |
2.15 | ethene -1,2-diyloxy | |
2.16 | Excluded by Decree of the Government of the Republic of Kazakhstan dated 23.01.2024 № 22 (shall come into effect upon the expiration of ten calendar days after the day of its first official publication). |